150710-72-8 Usage
Uses
Used in Pharmaceutical Industry:
Calyxamine B is used as a potential therapeutic agent for the treatment of inflammatory and oxidative stress-related diseases due to its potent anti-inflammatory and antioxidant properties. Its ability to modulate biological processes associated with inflammation and oxidative stress makes it a valuable compound for further research and development in this field.
Used in Anticancer Applications:
Calyxamine B is used as an anticancer agent, particularly for its cytotoxic activity against certain cancer cell lines. Its potential to target and inhibit the growth of cancer cells, along with its unique chemical structure, positions it as a candidate for further exploration in oncology research and drug development.
Used in Drug Development Research:
Calyxamine B is used as a subject of study in drug development research to explore its potential applications and mechanisms of action in treating various diseases. Its distinctive chemical structure and promising biological activities make it an interesting compound for scientists to investigate its therapeutic potential and optimize its use in medical treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 150710-72-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,7,1 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 150710-72:
(8*1)+(7*5)+(6*0)+(5*7)+(4*1)+(3*0)+(2*7)+(1*2)=98
98 % 10 = 8
So 150710-72-8 is a valid CAS Registry Number.
150710-72-8Relevant academic research and scientific papers
Meza-León, Rosa-L.,García, Alvaro Dávila,Sartillo-Piscil, Fernando,Quintero, Leticia,Rivadeneyra, Martha Sosa,Cruz-Gregorio, Silvano
, p. 6852 - 6854 (2013)
A two-step synthesis of naturally occurring alkaloids calyxamines A and B featuring a tandem Mannich–aldol condensation reaction under solvent free conditions, and their inhibitory activity against acetylcholinesterase (AChE) is reported.
